Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 191 articles:
HTML format
Text format



Single Articles


    August 2018
  1. HARIMOTO N, Hoshino H, Muranushi R, Hagiwara K, et al
    Skeletal Muscle Volume and Intramuscular Adipose Tissue Are Prognostic Predictors of Postoperative Complications After Hepatic Resection.
    Anticancer Res. 2018;38:4933-4939.
    PubMed     Text format     Abstract available


  2. YU JI, Choi GS, Lim DH, Lee E, et al
    Treatment of Naive HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection Versus TACE Followed by Radiotherapy.
    Anticancer Res. 2018;38:4919-4925.
    PubMed     Text format     Abstract available


  3. ROSSI L, Biagioni C, McCartney A, Moretti E, et al
    Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the Literature.
    Anticancer Res. 2018;38:4839-4845.
    PubMed     Text format     Abstract available


  4. MORIMOTO M, Honjo S, Sakamoto T, Uchinaka EI, et al
    Pilot Study of Probe-based Confocal Laser Endomicroscopy with Fluorescein-dripping Method for Liver Tumors.
    Anticancer Res. 2018;38:4775-4781.
    PubMed     Text format     Abstract available


  5. SHIROYAMA T, Suzuki H, Tamiya M, Tamiya A, et al
    Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:4723-4729.
    PubMed     Text format     Abstract available


    July 2018
  6. UCHIYAMA H, Komatsu KI, Nakata A, Sato K, et al
    Global Liver Gene Expression Analysis on a Murine Hepatic Steatosis Model Treated with Mulberry (Morus alba L.) Leaf Powder.
    Anticancer Res. 2018;38:4305-4311.
    PubMed     Text format     Abstract available


  7. NOH CK, Wang HJ, Kim CM, Kim J, et al
    EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:4101-4109.
    PubMed     Text format     Abstract available


  8. KOGA Y, Beppu T, Miyata T, Kitano Y, et al
    Predicting Poorly Differentiated Hepatocellular Carcinoma that Meets the Milan Criteria.
    Anticancer Res. 2018;38:4093-4099.
    PubMed     Text format     Abstract available


  9. SCHMIDT TM, Liu LI, Abraham IE, Uy AB, et al
    Efficacy and Safety of Sorafenib in a Racially Diverse Patient Population with Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:4027-4034.
    PubMed     Text format     Abstract available


  10. TSAI TJ, Chao WY, Chen CC, Chen YJ, et al
    Gelsolin-like Actin-capping Protein (CapG) Overexpression in the Cytoplasm of Human Hepatocellular Carcinoma, Associated with Cellular Invasion, Migration and Tumor Prognosis.
    Anticancer Res. 2018;38:3943-3950.
    PubMed     Text format     Abstract available


  11. INAGAWA H, Saika T, Nishiyama N, Nisizawa T, et al
    Dewaxed Brown Rice Feed Improves Fatty Liver in Obese and Diabetic Model Mice.
    Anticancer Res. 2018;38:4339-4345.
    PubMed     Text format     Abstract available


  12. JELSKI W, Wolszczak-Biedrzycka B, Zasimowicz-Majewska E, Orywal K, et al
    Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase Activity in the Serum of Patients with Non-alcoholic Fatty Liver Disease.
    Anticancer Res. 2018;38:4005-4009.
    PubMed     Text format     Abstract available


  13. MIRKA H, Duras P, Baxa J, Korcakova E, et al
    Contribution of Computed Tomographic Angiography to Pretreatment Planning of Radio-embolization of Liver Tumors.
    Anticancer Res. 2018;38:3825-3829.
    PubMed     Text format     Abstract available


    June 2018
  14. SHIBA S, Shibuya K, Katoh H, Koyama Y, et al
    No Deterioration in Clinical Outcomes of Carbon Ion Radiotherapy for Sarcopenia Patients with Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:3579-3586.
    PubMed     Text format     Abstract available


  15. ANDO K, Sakoda M, Ueno S, Hiwatashi K, et al
    Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:3411-3418.
    PubMed     Text format     Abstract available


  16. SAWAZAKI S, Numata M, Morita J, Maezawa Y, et al
    Safety of Laparoscopic Surgery for Colorectal Cancer in Patients with Severe Comorbidities.
    Anticancer Res. 2018;38:3767-3772.
    PubMed     Text format     Abstract available


  17. TRESKA V, Topolcan O, Zoubkova V, Treskova I, et al
    Perioperative Tumour Marker Levels as Prognostic Factors for Surgical Treatment of Breast Cancer Liver Metastases.
    Anticancer Res. 2018;38:3647-3652.
    PubMed     Text format     Abstract available


    May 2018
  18. MACHAIRAS N, Papaconstantinou D, Stamopoulos P, Prodromidou A, et al
    The Emerging Role of Laparoscopic Liver Resection in the Treatment of Recurrent Hepatocellular Carcinoma: A Systematic Review.
    Anticancer Res. 2018;38:3181-3186.
    PubMed     Text format     Abstract available


  19. YOSHIDA M, Beppu T, Shiraishi S, Tsuda N, et al
    Liver Function in Areas of Hepatic Venous Congestion After Hepatectomy for Liver Cancer: (99m)Tc-GSA SPECT/CT Fused Imaging Study.
    Anticancer Res. 2018;38:3089-3095.
    PubMed     Text format     Abstract available


  20. IWABU J, Namikawa T, Tsuda S, Kitagawa H, et al
    Successful Distal Gastrectomy for Gastric Cancer with Child-Pugh Class B Alcoholic Liver Cirrhosis.
    Anticancer Res. 2018;38:3085-3087.
    PubMed     Text format     Abstract available


  21. LAI JZ, Zhou Y, Cao D
    Synchronous Pancreatic Ductal Adenocarcinoma and Hepatocellular Carcinoma: Report of a Case and Review of the Literature.
    Anticancer Res. 2018;38:3009-3012.
    PubMed     Text format     Abstract available


  22. SHIH YL, Huang YH, Lin KH, Chu YD, et al
    Identification of Functional Thyroid Stimulating Hormone Receptor and TSHR Gene Mutations in Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:2793-2802.
    PubMed     Text format     Abstract available


  23. HABERL EM, Pohl R, Rein-Fischboeck L, Feder S, et al
    Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and Hepatocarcinogenesis.
    Anticancer Res. 2018;38:2649-2657.
    PubMed     Text format     Abstract available


  24. ALFONSO PG, Podesta MC, Martin AM, Codeisido MB, et al
    Chemotherapy Plus Bevacizumab as Neoadjuvant or Conversion Treatment in Patients with Colorectal Liver Metastases.
    Anticancer Res. 2018;38:3069-3077.
    PubMed     Text format     Abstract available


  25. CHANG J, Charalel R, Noda C, Ramaswamy R, et al
    Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Versus Radioembolization.
    Anticancer Res. 2018;38:3063-3068.
    PubMed     Text format     Abstract available


  26. DESHWAR A, Margonis GA, Andreatos N, Barbon C, et al
    Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.
    Anticancer Res. 2018;38:2891-2895.
    PubMed     Text format     Abstract available


  27. NASSEREDDINE S, Alsubait S, Tabbara I
    Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
    Anticancer Res. 2018;38:2597-2605.
    PubMed     Text format     Abstract available


    April 2018
  28. KANG WH, Tak E, Hwang S, Song GW, et al
    Metformin-associated Chemopreventive Effects on Recurrence After Hepatic Resection of Hepatocellular Carcinoma: From In Vitro to a Clinical Study.
    Anticancer Res. 2018;38:2399-2407.
    PubMed     Text format     Abstract available


  29. TSAI JJ, Hsu FT, Pan PJ, Chen CW, et al
    Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo.
    Anticancer Res. 2018;38:2119-2125.
    PubMed     Text format     Abstract available


  30. SATAKE T, Suetsugu A, Nakamura M, Hasegawa K, et al
    Differential Organ-targeting and Cellular Characteristics of Metastatic Human Pancreatic Cancer Cell Lines in Mouse Models.
    Anticancer Res. 2018;38:1927-1935.
    PubMed     Text format     Abstract available


    March 2018
  31. TOYA R, Saito T, Shiraishi S, Kai Y, et al
    Dose-function Histogram Evaluation Using (99m)Tc-GSA SPECT/CT Images for Stereotactic Body Radiation Therapy Planning for Hepatocellular Carcinoma Patients: A Dosimetric Parameter Comparison.
    Anticancer Res. 2018;38:1511-1516.
    PubMed     Text format     Abstract available


  32. OKANO N, Kasuga A, Kawai K, Yamauchi Y, et al
    The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer.
    Anticancer Res. 2018;38:1755-1761.
    PubMed     Text format     Abstract available


  33. FILIPESCU A, Balescu I, Bacalbasa N
    Upper Abdominal Resection for Isolated Metastatic Lesions in Recurrent Cervical Cancer.
    Anticancer Res. 2018;38:1659-1663.
    PubMed     Text format     Abstract available


  34. KINOSHITA K, Beppu T, Miyata T, Kuramoto K, et al
    A Case of 15-Year Recurrence-free Survival After Microwave Coagulation Therapy for Liver Metastasis from Gastric Cancer.
    Anticancer Res. 2018;38:1595-1598.
    PubMed     Text format     Abstract available


  35. MORIS D, Ntanasis-Stathopoulos I, Tsilimigras DI, Vagios S, et al
    Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
    Anticancer Res. 2018;38:1267-1278.
    PubMed     Text format     Abstract available


    February 2018
  36. IMAI K, Yamashita YI, Yusa T, Nakao Y, et al
    Microvascular Invasion in Small-sized Hepatocellular Carcinoma: Significance for Outcomes Following Hepatectomy and Radiofrequency Ablation.
    Anticancer Res. 2018;38:1053-1060.
    PubMed     Text format     Abstract available


  37. TSUKAMOTO M, Yamashita YI, Imai K, Umezaki N, et al
    Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
    Anticancer Res. 2018;38:1047-1052.
    PubMed     Text format     Abstract available


  38. SATTLER T, Bredt C, Surwald S, Rust C, et al
    Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 mum for the Treatment of Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:1025-1032.
    PubMed     Text format     Abstract available


  39. UEMOTO K, Doi H, Shiomi H, Yamada K, et al
    Clinical Assessment of Micro-residual Tumors during Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:945-954.
    PubMed     Text format     Abstract available


  40. HORTON CE, Kamal M, Leslie M, Zhang R, et al
    Circulating Tumor Cells Accurately Predicting Progressive Disease After Treatment in a Patient with Non-small Cell Lung Cancer Showing Response on Scans.
    Anticancer Res. 2018;38:1073-1076.
    PubMed     Text format     Abstract available


  41. OSADA S, Gotoh A, Yokoi R, Tsuchiya H, et al
    Effective Timing of Surgical Resection of Colorectal Cancer Liver Metastases During Chemotherapy.
    Anticancer Res. 2018;38:737-743.
    PubMed     Text format     Abstract available


  42. DOI H, Beppu N, Kitajima K, Kuribayashi K, et al
    Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
    Anticancer Res. 2018;38:591-599.
    PubMed     Text format     Abstract available


  43. CEAUSU AR, Ciolofan A, Cimpean AM, Magheti A, et al
    The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin.
    Anticancer Res. 2018;38:811-816.
    PubMed     Text format     Abstract available


    January 2018
  44. KURAMOTO K, Beppu T, Nitta H, Imai K, et al
    Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.
    Anticancer Res. 2018;38:525-531.
    PubMed     Text format     Abstract available


  45. YOSHIMOTO T, Imura S, Morine Y, Ikemoto T, et al
    The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy.
    Anticancer Res. 2018;38:501-507.
    PubMed     Text format     Abstract available


  46. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
    The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Anticancer Res. 2018;38:313-320.
    PubMed     Text format     Abstract available


  47. VIRGILIO E, Cavallini M
    Managing Focal Nodular Hyperplasia of the Liver: Surgery or Minimally-invasive Approaches? A Review of the Preferable Treatment Options.
    Anticancer Res. 2018;38:33-36.
    PubMed     Text format     Abstract available


    December 2017
  48. TSUKAMOTO M, Yamashita YI, Imai K, Umezaki N, et al
    Predictors of Cure of Intrahepatic Cholangiocarcinoma After Hepatic Resection.
    Anticancer Res. 2017;37:6971-6975.
    PubMed     Text format     Abstract available


  49. LIANG YH, Shao YY, Chen HM, Cheng AL, et al
    Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
    Anticancer Res. 2017;37:7095-7104.
    PubMed     Text format     Abstract available


  50. MIYATA T, Beppu T, Higashi T, Nakagawa S, et al
    A Glissonean Approach with Individual Isolation During Right Hemi-Hepatectomy After Portal Vein Embolization.
    Anticancer Res. 2017;37:7069-7071.
    PubMed     Text format     Abstract available


  51. SHIBATA H, Ohike N, Norose T, Isobe T, et al
    Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.
    Anticancer Res. 2017;37:7063-7068.
    PubMed     Text format     Abstract available


  52. CAIVANO D, Valeriani M, Russo I, Bonome P, et al
    Stereotactic Body Radiation Therapy in Primary and Metastatic Liver Disease.
    Anticancer Res. 2017;37:7005-7010.
    PubMed     Text format     Abstract available


    November 2017
  53. BAI YC, Hsia YC, Lin YT, Chen KH, et al
    Effect of Tumor Microenvironment on Selective Uptake of Boric Acid in HepG2 Human Hepatoma Cells.
    Anticancer Res. 2017;37:6347-6353.
    PubMed     Text format     Abstract available


  54. CIRIMBEI C, Rotaru V, Chitoran E, Pavaleanu O, et al
    Immediate and Long-term Results of Radiofrequency Ablation for Colorectal Liver Metastases.
    Anticancer Res. 2017;37:6489-6494.
    PubMed     Text format     Abstract available


  55. SATONAKA H, Ishida K, Takai M, Koide R, et al
    (-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways.
    Anticancer Res. 2017;37:6071-6077.
    PubMed     Text format     Abstract available


    October 2017
  56. IMURA S, Yamada S, Saito YU, Iwahashi S, et al
    miR-223 and Stathmin-1 Expression in Non-tumor Liver Tissue of Patients with Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:5877-5883.
    PubMed     Text format     Abstract available


  57. MORINE Y, Imura S, Ikemoto T, Iwahashi S, et al
    CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
    Anticancer Res. 2017;37:5701-5705.
    PubMed     Text format     Abstract available


  58. RATHMANN N, Kara K, Budjan J, Henzler T, et al
    Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
    Anticancer Res. 2017;37:5681-5685.
    PubMed     Text format     Abstract available


  59. IKEMOTO T, Shimada M, Ishikawa D, Kawashita Y, et al
    Peripheral Tr1 and Foxp3+ Treg as Markers of Recurrent Malignancies in Patients with Hepato-Biliary Pancreatic Cancers.
    Anticancer Res. 2017;37:5541-5552.
    PubMed     Text format     Abstract available


  60. KISHIMOTO S, Yasuda M, Fukushima S
    Changes in the Expression of Various Transporters as Influencing Factors of Resistance to Cisplatin.
    Anticancer Res. 2017;37:5477-5484.
    PubMed     Text format     Abstract available


    September 2017
  61. SAKABE T, Azumi J, Umekita Y, Toriguchi K, et al
    Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:4881-4888.
    PubMed     Text format     Abstract available


  62. BI YE, Zhou Y, Wang M, Li L, et al
    Targeted Delivery of Cordycepin to Liver Cancer Cells Using Transferrin-conjugated Liposomes.
    Anticancer Res. 2017;37:5207-5214.
    PubMed     Text format     Abstract available


  63. CICERO G, Lo Re G, DE Luca R, Vernuccio F, et al
    Role of Densitometric Criteria in Evaluation of Effectiveness of Antiangiogenic Therapies in Metastatic Colorectal Cancer: An Italian Clinical Experience.
    Anticancer Res. 2017;37:5187-5192.
    PubMed     Text format     Abstract available


  64. DIVELLA R, Daniele A, DE Luca R, Simone M, et al
    Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer.
    Anticancer Res. 2017;37:4867-4871.
    PubMed     Text format     Abstract available


    August 2017
  65. WANG L, Liu M, Liu L, Zheng Y, et al
    MR-guided Percutaneous Biopsy of Focal Hepatic Dome Lesions with Free-hand Combined with MR Fluoroscopy Using 1.0-T Open High-field Scanner.
    Anticancer Res. 2017;37:4635-4641.
    PubMed     Text format     Abstract available


  66. GONG Z, Chi C, Huang X, Chu H, et al
    Cyclophilin A Is Overexpressed in Hepatocellular Carcinoma and Is Associated with the Cell Cycle.
    Anticancer Res. 2017;37:4443-4447.
    PubMed     Text format     Abstract available


  67. ZHANG WG, Yin XC, Liu XF, Meng KW, et al
    Puerarin Induces Hepatocellular Carcinoma Cell Apoptosis Modulated by MAPK Signaling Pathways in a Dose-dependent Manner.
    Anticancer Res. 2017;37:4425-4431.
    PubMed     Text format     Abstract available


    July 2017
  68. HARADA N, Yoshizumi T, Yamashita YI, Soejima Y, et al
    Impact and Prediction of Lymph Node Involvement in Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.
    Anticancer Res. 2017;37:3763-3769.
    PubMed     Text format     Abstract available


  69. KRAUTBAUER S, Weiss TS, Wiest R, Schacherer D, et al
    Diagnostic Value of Systemic Cholesteryl Ester/Free Cholesterol Ratio in Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3527-3535.
    PubMed     Text format     Abstract available


  70. HAYASHI T, Yamashita T, Okada H, Oishi N, et al
    A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3397-3403.
    PubMed     Text format     Abstract available


  71. ISHII F, Yoshida Y, Yamauchi Y, Aisu N, et al
    Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated alphabeta T-cells.
    Anticancer Res. 2017;37:3933-3939.
    PubMed     Text format     Abstract available


  72. SHIBA I, Kouzaki R, Yamada H, Endo Y, et al
    Design and Synthesis of Novel Anti-metastatic Hypoxic Cytotoxin TX-2137 Targeting AKT Kinase.
    Anticancer Res. 2017;37:3877-3883.
    PubMed     Text format     Abstract available


  73. SETO K, Sakabe T, Itaba N, Azumi J, et al
    A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Anticancer Res. 2017;37:3569-3579.
    PubMed     Text format     Abstract available


  74. NAKAMURA M, Suetsugu A, Hasegawa K, Matsumoto T, et al
    Choline-Deficient-Diet-Induced Fatty Liver Is a Metastasis-Resistant Microenvironment.
    Anticancer Res. 2017;37:3429-3434.
    PubMed     Text format     Abstract available


    June 2017
  75. WAKIYAMA S, Matsumoto M, Haruki K, Gocho T, et al
    Clinical Features and Outcome of Surgical Patients with Non-B Non-C Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3207-3213.
    PubMed     Text format     Abstract available


  76. MATSUMOTO T, Ichikawa H, Imai J, Hayashi T, et al
    Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3183-3187.
    PubMed     Text format     Abstract available


  77. LIN CL, Chien RN, Liang KH, Ke PY, et al
    Intrahepatic HCV RNA Level and Genotype 1 Independently Associate with Hepatic Reticulon 3 Expression.
    Anticancer Res. 2017;37:2885-2891.
    PubMed     Text format     Abstract available


    May 2017
  78. MIYATA T, Yamashita YI, Yamao T, Umezaki N, et al
    Clinical Benefits of Lymph Node Dissection in Intrahepatic Cholangiocarcinoma: A Retrospective Single-institution Study.
    Anticancer Res. 2017;37:2673-2677.
    PubMed     Text format     Abstract available


  79. HASHIMOTO M, Kobayashi T, Ishiyama K, Ide K, et al
    Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy.
    Anticancer Res. 2017;37:2625-2631.
    PubMed     Text format     Abstract available


  80. LU LC, Chen PJ, Yeh YC, Hsu CH, et al
    Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study.
    Anticancer Res. 2017;37:2593-2599.
    PubMed     Text format     Abstract available


  81. KANAJI N, Kita N, Kadowaki N, Bandoh S, et al
    Fibronectin and Hepatocyte Growth Factor Produced by Lung Fibroblasts Augment Migration and Invasion of Malignant Pleural Mesothelioma Cells.
    Anticancer Res. 2017;37:2393-2400.
    PubMed     Text format     Abstract available


  82. BARABINO M, Gatti A, Santambrogio R, Polizzi M, et al
    Intraoperative Local Ablative Therapies Combined with Surgery for the Treatment of Bilobar Colorectal Liver Metastases.
    Anticancer Res. 2017;37:2743-2750.
    PubMed     Text format     Abstract available


    April 2017
  83. MALKI A, El-Sharkawy A, El Syaed M, Bergmeier S, et al
    Antitumor Activities of the Novel Isosteviol Derivative 10C Against Liver Cancer.
    Anticancer Res. 2017;37:1591-1601.
    PubMed     Text format     Abstract available


  84. TAHARA T, Tahara S, Horiguchi N, Kawamura T, et al
    Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis.
    Anticancer Res. 2017;37:1997-2001.
    PubMed     Text format     Abstract available


  85. OTTAIANO A, Capozzi M, DE Divitiis C, VON Arx C, et al
    Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.
    Anticancer Res. 2017;37:1975-1978.
    PubMed     Text format     Abstract available


  86. HARADA N, Yoshizumi T, Maeda T, Kayashima H, et al
    Preoperative Pancreatic Stiffness by Real-time Tissue Elastography to Predict Pancreatic Fistula After Pancreaticoduodenectomy.
    Anticancer Res. 2017;37:1909-1915.
    PubMed     Text format     Abstract available


    March 2017
  87. DE PASQUALE MD, de Ville de Goyet J, Monti L, Grimaldi C, et al
    Bevacizumab Combined with Chemotherapy in Children Affected by Hepatocellular Carcinoma: a Single-center Experience.
    Anticancer Res. 2017;37:1489-1493.
    PubMed     Text format     Abstract available


  88. ITOH S, Uchiyama H, Ikeda Y, Morita K, et al
    Post-hepatectomy Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma: Risk Factor Analysis to Overcome this Problematic Complication.
    Anticancer Res. 2017;37:1381-1385.
    PubMed     Text format     Abstract available


  89. MARQUES LA, Semprebon SC, Sartori D, DE Fatima A, et al
    Comparison of the Effects of Monastrol and Oxomonastrol on Human Hepatoma Cell Line HepG2/C3A.
    Anticancer Res. 2017;37:1197-1204.
    PubMed     Text format     Abstract available


  90. YOSHIKAWA M, Morine Y, Ikemoto T, Imura S, et al
    Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition.
    Anticancer Res. 2017;37:1169-1175.
    PubMed     Text format     Abstract available


  91. KOMATSU H, Masuda T, Iguchi T, Nambara S, et al
    Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:1083-1090.
    PubMed     Text format     Abstract available


  92. TRESKA V, Fichtl J, Bruha J, Liska V, et al
    Liver Resections for Colorectal Metastases in Patients Aged Over 75 Years.
    Anticancer Res. 2017;37:1529-1533.
    PubMed     Text format     Abstract available


  93. D'ONOFRIO M, Cingarlini S, Ortolani S, Crosara S, et al
    Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment.
    Anticancer Res. 2017;37:1305-1311.
    PubMed     Text format     Abstract available


    February 2017
  94. IKEGAMI T, Yoshizumi T, Kawasaki J, Nagatsu A, et al
    Surgical Resection for Lymph Node Metastasis After Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:891-895.
    PubMed     Text format     Abstract available


  95. FRIEDMAN P, Lai JP
    Liver Metastasis of Urothelial Carcinoma with Hepatoid Features: An Unusual Morphological Finding.
    Anticancer Res. 2017;37:801-804.
    PubMed     Text format     Abstract available


  96. CHEN YL, Huang WC, Yao HL, Chen PM, et al
    Down-regulation of RASA1 Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:781-785.
    PubMed     Text format     Abstract available


  97. ZENG H, Wu HC, Wang Q, Yang HI, et al
    Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.
    Anticancer Res. 2017;37:637-644.
    PubMed     Text format     Abstract available


  98. ZHANG S, Tang D, Zang W, Yin G, et al
    Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:465-473.
    PubMed     Text format     Abstract available


  99. MAGISTRI P, Tarantino G, Ballarin R, Berretta M, et al
    The Evolving Role of Local Treatments for HCC in the Third Millennium.
    Anticancer Res. 2017;37:389-401.
    PubMed     Text format     Abstract available


  100. RYU SH, Heo SH, Park EY, Choi KC, et al
    Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-targeted Genes.
    Anticancer Res. 2017;37:607-614.
    PubMed     Text format     Abstract available


    January 2017

  101. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. General and Surgical Pathology. Volumes 1, 2, 3, 4.
    Anticancer Res. 2017;37:361.
    PubMed     Text format    



  102. Hepatocellular Carcinoma. Diagnosis and Treatment. Third Edition.
    Anticancer Res. 2017;37:361.
    PubMed     Text format    


  103. SONOHARA F, Inokawa Y, Kanda M, Nishikawa Y, et al
    Association of Inflammasome Components in Background Liver with Poor Prognosis After Curatively-resected Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:293-300.
    PubMed     Text format     Abstract available


  104. CHIANG IT, Chen WT, Tseng CW, Chen YC, et al
    Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells.
    Anticancer Res. 2017;37:161-167.
    PubMed     Text format     Abstract available


  105. NASS N, Streit S, Wybranski C, Jurgens J, et al
    Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
    Anticancer Res. 2017;37:87-93.
    PubMed     Text format     Abstract available


  106. FUJIYOSHI K, Yamamoto G, Takenoya T, Takahashi A, et al
    Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Anticancer Res. 2017;37:239-247.
    PubMed     Text format     Abstract available


  107. RADES D, Bolm L, Schild SE, Bartscht T, et al
    Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer.
    Anticancer Res. 2017;37:203-206.
    PubMed     Text format     Abstract available


  108. MORIS D, Dimitroulis D, Vernadakis S, Papalampros A, et al
    Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes.
    Anticancer Res. 2017;37:9-14.
    PubMed     Text format     Abstract available


    December 2016
  109. YAMASHITA YI, Wang H, Kurihara T, Tsujita E, et al
    Clinical Significances of Preoperative Classification of Intrahepatic Cholangiocarcinoma: Different Characteristics of Perihilar vs. Peripheral ICC.
    Anticancer Res. 2016;36:6563-6569.
    PubMed     Text format     Abstract available


  110. MA X, Wang X, Yang C, Wang Z, et al
    DANCR Acts as a Diagnostic Biomarker and Promotes Tumor Growth and Metastasis in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:6389-6398.
    PubMed     Text format     Abstract available


  111. TANG M, Etokidem E, Lai K
    The Leloir Pathway of Galactose Metabolism - A Novel Therapeutic Target for Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:6265-6271.
    PubMed     Text format     Abstract available


    November 2016
  112. GIORGIO A, Merola MG, Montesarchio L, Merola F, et al
    Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial.
    Anticancer Res. 2016;36:6179-6183.
    PubMed     Text format     Abstract available


  113. GARNIER A, Ilmer M, Kappler R, Berger M, et al
    Therapeutic Innovations for Targeting Hepatoblastoma.
    Anticancer Res. 2016;36:5577-5592.
    PubMed     Text format     Abstract available


  114. TAK E, Hwang S, Lee HC, Ko GY, et al
    Apoptosis of Hepatitis B Virus-expressing Liver Tumor Cells Induced by a High Concentration of Nucleos(t)ide Analogue.
    Anticancer Res. 2016;36:6059-6069.
    PubMed     Text format     Abstract available


    October 2016
  115. HARIMOTO N, Yoshizumi T, Shimagaki T, Nagatsu A, et al
    Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5537-5542.
    PubMed     Text format     Abstract available


  116. KORNBERG A, Witt U, Kornberg J, Ceyhan GO, et al
    Prognostic Impact of Intraoperative Blood Loss in Liver Transplant Patients with Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5355-5364.
    PubMed     Text format     Abstract available


  117. SHEN J, Yeh CC, Wang Q, Gurvich I, et al
    Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation.
    Anticancer Res. 2016;36:5307-5314.
    PubMed     Text format     Abstract available


  118. HIWATASHI K, Ueno S, Sakoda M, Iino S, et al
    Expression of Maternal Embryonic Leucine Zipper Kinase (MELK) Correlates to Malignant Potentials in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5183-5188.
    PubMed     Text format     Abstract available


  119. HASS HG, Vogel U, Scheurlen M, Jobst J, et al
    Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5087-5095.
    PubMed     Text format     Abstract available


  120. CHANG CD, Lin PY, Hsu JL, Shih WL, et al
    Ursolic Acid Suppresses Hepatitis B Virus X Protein-mediated Autophagy and Chemotherapeutic Drug Resistance.
    Anticancer Res. 2016;36:5097-5107.
    PubMed     Text format     Abstract available


  121. ALT M, Truant S, Renaud-Vantroys T, Sequier C, et al
    Bevacizumab Associated with Chemotherapy for Initially Non-resectable Liver Metastases from Colorectal Cancer: a Case-Control Study.
    Anticancer Res. 2016;36:5551-5555.
    PubMed     Text format     Abstract available


    September 2016
  122. KAWAGUCHI D, Hiroshima Y, Matsuo K, Endo I, et al
    Hepatic Resection After Prehepatectomy Chemotherapy for Metastatic Colorectal Cancer: A Propensity-Matched Analysis.
    Anticancer Res. 2016;36:4725-30.
    PubMed     Text format     Abstract available


  123. INOKAWA Y, Sonohara F, Kanda M, Hayashi M, et al
    Correlation Between Poor Prognosis and Lower TPPP Gene Expression in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:4639-45.
    PubMed     Text format     Abstract available


  124. NISHIMURA M, Murayama Y, Harada K, Kamada Y, et al
    Photodynamic Diagnosis of Hepatocellular Carcinoma Using 5-Aminolevulinic Acid.
    Anticancer Res. 2016;36:4569-74.
    PubMed     Text format     Abstract available


  125. KOGAME M, Nagai H, Shinohara M, Igarashi Y, et al
    Th2 Dominance Might Induce Carcinogenesis in Patients with HCV-related Liver Cirrhosis.
    Anticancer Res. 2016;36:4529-36.
    PubMed     Text format     Abstract available


  126. PIKOULIS E, Margonis GA, Andreatos N, Sasaki K, et al
    Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases.
    Anticancer Res. 2016;36:4805-11.
    PubMed     Text format     Abstract available


  127. KAWAGUCHI D, Hiroshima Y, Matsuo K, Endo I, et al
    Parenchymal Congestion Is Important for Rapid Regeneration of the Future Liver Remnant Following the ALPPS Procedure.
    Anticancer Res. 2016;36:4731-8.
    PubMed     Text format     Abstract available


    August 2016
  128. BUDJAN J, Sauter EA, Morelli JN, Nolden M, et al
    Semi-automatic Volumetric Measurement of Treatment Response in Hepatocellular Carcinoma After Trans-arterial Chemoembolization.
    Anticancer Res. 2016;36:4353-8.
    PubMed     Text format     Abstract available


  129. ITOH S, Kohnoe S, Shirabe K, Yoshida D, et al
    Validity of Hepatic or Pancreatic Resection for Elderly Patients Aged 85 Years or Older at a Single Community Hospital in Japan.
    Anticancer Res. 2016;36:4289-92.
    PubMed     Text format     Abstract available


  130. YEH CN, Wang SY, Chen YY, Chen MH, et al
    A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2016;36:4249-58.
    PubMed     Text format     Abstract available


  131. NANASHIMA A, Izumino H, Sumida Y, Tominaga T, et al
    Relationship Between Urinary 8-hydroxydeoxyguanine (8-OHdG) Levels and Clinicopathological Findings in Hepatobiliary Malignancies.
    Anticancer Res. 2016;36:3899-903.
    PubMed     Text format     Abstract available


  132. DJAAFAR S, Dunand-Sautier I, Gonelle-Gispert C, Lacotte S, et al
    Enoxaparin Attenuates Mouse Colon Cancer Liver Metastases by Inhibiting Heparanase and Interferon-gamma-inducible Chemokines.
    Anticancer Res. 2016;36:4019-32.
    PubMed     Text format     Abstract available


    July 2016
  133. ETO D, Hisaka T, Horiuchi H, Uchida S, et al
    Expression of HSP27 in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:3775-9.
    PubMed     Text format     Abstract available


  134. HONDA T, Inagawa H
    Gene Expression in Lipopolysaccharide-treated Human Monocytes Following Interaction with Hepatic Cancer Cells.
    Anticancer Res. 2016;36:3699-704.
    PubMed     Text format     Abstract available


  135. DINH VY, Bhatia S, Narayanan G, Yrizarry J, et al
    Pilot Study of Intrahepatic Artery Chemotherapy in Combination with Sorafenib in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:3555-63.
    PubMed     Text format     Abstract available


  136. HATOOKA M, Kawaoka T, Aikata H, Morio K, et al
    Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
    Anticancer Res. 2016;36:3523-9.
    PubMed     Text format     Abstract available


  137. ALIBERTI C, Carandina R, Sarti D, Mulazzani L, et al
    Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
    Anticancer Res. 2016;36:3515-21.
    PubMed     Text format     Abstract available


  138. SHAH BK, Kandel P, Khanal A
    Second Primary Malignancies in Hepatocellular Cancer - A US Population-based Study.
    Anticancer Res. 2016;36:3511-4.
    PubMed     Text format     Abstract available


  139. HARADA N, Maeda T, Yoshizumi T, Ikeda T, et al
    Laparoscopic Liver Resection Is a Feasible Treatment for Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Anticancer Res. 2016;36:3489-97.
    PubMed     Text format     Abstract available


  140. AKINWANDE O, Scoggins C, Martin RC
    Early Experience with 70-150 mum Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
    Anticancer Res. 2016;36:3413-8.
    PubMed     Text format     Abstract available


  141. SAKAMOTO T, Ishii Y, Shiba H, Furukawa K, et al
    Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production.
    Anticancer Res. 2016;36:3301-6.
    PubMed     Text format     Abstract available


  142. ELLERKAMP V, Bortel N, Schmid E, Kirchner B, et al
    Photodynamic Therapy Potentiates the Effects of Curcumin on Pediatric Epithelial Liver Tumor Cells.
    Anticancer Res. 2016;36:3363-72.
    PubMed     Text format     Abstract available


  143. PASCALE F, Ghegediban SH, Bedouet L, Namur J, et al
    bFGF Up-regulation Reduces Spontaneous Necrosis of VX2 Tumors Without Increasing Tumoral Microvascular Density.
    Anticancer Res. 2016;36:3315-20.
    PubMed     Text format     Abstract available


  144. MATSUI T, Nagata N, Hirata K, Okazaki S, et al
    Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX Trial.
    Anticancer Res. 2016;36:3437-43.
    PubMed     Text format     Abstract available


    June 2016
  145. OKADA K, Kawai M, Ueno M, Hirono S, et al
    Depth of Hepatic Infiltration and Lymph Node Swelling as Factors for Considering Surgery for T2-4 Gallbladder Carcinoma Patients.
    Anticancer Res. 2016;36:3075-80.
    PubMed     Text format     Abstract available


  146. ITOH S, Yoshizumi T, Kimura K, Okabe H, et al
    Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:3029-34.
    PubMed     Text format     Abstract available


  147. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    Hepatic Resection for Liver Metastases from Cervical Cancer Is Safe and May Have Survival Benefit.
    Anticancer Res. 2016;36:3023-7.
    PubMed     Text format     Abstract available


  148. CHEN YL, Chen PM, Lin PY, Hsiau YT, et al
    ABCG2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients.
    Anticancer Res. 2016;36:2983-8.
    PubMed     Text format     Abstract available


  149. KOMATSU H, Iguchi T, Masuda T, Ueda M, et al
    HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:2767-73.
    PubMed     Text format     Abstract available


  150. YANG H, Ding R, Tong Z, Huang J, et al
    siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:2675-82.
    PubMed     Text format     Abstract available


  151. BRADATSCH A, Kornprat P, Bacher H, Cerwenka H, et al
    The Value of Lymph Node Dissection in the Surgery of Colorectal Cancer Liver Metastases.
    Anticancer Res. 2016;36:2993-7.
    PubMed     Text format     Abstract available


  152. RATHMANN N, Budjan J, Mari F, Grimm R, et al
    Semiautomatic Whole-lesion Apparent Diffusion Coefficient Assessment for Early Prediction of Liver Tumor Response to Radioembolization.
    Anticancer Res. 2016;36:2961-6.
    PubMed     Text format     Abstract available


  153. SEMAAN A, Branchi V, Marowsky AL, VON Websky M, et al
    Incidentally Detected Focal Liver Lesions - A Common Clinical Management Dilemma Revisited.
    Anticancer Res. 2016;36:2923-32.
    PubMed     Text format     Abstract available


    May 2016
  154. IGUCHI T, Komatsu H, Masuda T, Nambara S, et al
    Increased Copy Number of the Gene Encoding SF3B4 Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:2139-44.
    PubMed     Text format     Abstract available


  155. KIM CW, Roh SA, Tak KH, Koh BM, et al
    ZKSCAN3 Facilitates Liver Metastasis of Colorectal Cancer Associated with CEA-expressing Tumor.
    Anticancer Res. 2016;36:2397-406.
    PubMed     Text format     Abstract available


  156. YAMAUCHI K, Kokuryo T, Yokoyama Y, Uehara K, et al
    Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.
    Anticancer Res. 2016;36:2175-9.
    PubMed     Text format     Abstract available


  157. TRESKA V
    Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives.
    Anticancer Res. 2016;36:2065-71.
    PubMed     Text format     Abstract available


    April 2016
  158. NITTA H, Baba H, Sugimori K, Furuse J, et al
    Chemotherapy-induced Nausea and Vomiting in Patients with Hepatobiliary and Pancreatic Cancer Treated with Chemotherapy: A Prospective Observational Study by the CINV Study Group of Japan.
    Anticancer Res. 2016;36:1929-35.
    PubMed     Text format     Abstract available


  159. HIROSHIMA Y, Matsuo K, Kawaguchi D, Kikuchi Y, et al
    Modified Liver Hanging Maneuver for En-bloc Right-sided Hepatectomy Combined with Total Caudate Lobectomy for Colon-Cancer Liver Metastasis and Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:1729-35.
    PubMed     Text format     Abstract available


  160. UMEHARA M, Umehara Y, Takahashi K, Murata A, et al
    Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer.
    Anticancer Res. 2016;36:1949-54.
    PubMed     Text format     Abstract available


  161. FICHTL J, Treska V, Lysak D, Mirka H, et al
    Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell Application.
    Anticancer Res. 2016;36:1901-7.
    PubMed     Text format     Abstract available


  162. KAIBORI M, Matsui K, Ishizaki M, Iida H, et al
    Intraoperative Detection of Superficial Liver Tumors by Fluorescence Imaging Using Indocyanine Green and 5-aminolevulinic Acid.
    Anticancer Res. 2016;36:1841-9.
    PubMed     Text format     Abstract available


  163. BACALBASA N, Taras C, Orban C, Iliescu L, et al
    Atypical Right Hepatectomy for Liver Metastasis from Ovarian Leiomyosarcoma - A Case Report and Literature Review.
    Anticancer Res. 2016;36:1835-40.
    PubMed     Text format     Abstract available


  164. NISMAN B, Appelbaum L, Yutkin V, Nechushtan H, et al
    Serum Thymidine Kinase 1 Activity Following Nephrectomy for Renal Cell Carcinoma and Radiofrequency Ablation of Metastases to Lung and Liver.
    Anticancer Res. 2016;36:1791-7.
    PubMed     Text format     Abstract available


  165. MATSUMOTO T, Suetsugu A, Hasegawa K, Nakamura M, et al
    Color-Coded Imaging of Syngeneic Orthotopic Malignant Lymphoma Interacting with Host Stromal Cells During Metastasis.
    Anticancer Res. 2016;36:1473-8.
    PubMed     Text format     Abstract available


    March 2016
  166. WANG LG, Jiang WJ, Fan WJ, Zheng YB, et al
    Microwave Ablation: The Differences Between Biliary Cirrhosis and Normal Porcine Liver Using a Cooled-tip Electrode.
    Anticancer Res. 2016;36:1221-6.
    PubMed     Text format     Abstract available


    February 2016
  167. KIMURA K, Itoh S, Kurihara T, Yoshida Y, et al
    Predictors of Benign Status in Liver Tumors Under 3 cm in Diameter Misdiagnosed as Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:793-7.
    PubMed     Text format     Abstract available


  168. BARA T JR, Gurzu S, Jung I, Muresan M, et al
    Giant Cavernous Hepatic Hemangioma Diagnosed Incidentally in a Perimenopausal Obese Female with Endometrial Adenocarcinoma: A Case Report.
    Anticancer Res. 2016;36:769-72.
    PubMed     Text format     Abstract available


  169. WUBETU GY, Morine Y, Teraoku H, Yoshikawa M, et al
    High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Anticancer Res. 2016;36:757-62.
    PubMed     Text format     Abstract available


  170. DAVAADORJ M, Imura S, Saito YU, Morine Y, et al
    Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:659-64.
    PubMed     Text format     Abstract available


  171. MIYAMOTO Y, Sakamoto Y, Ohuchi M, Tokunaga R, et al
    Orbital Apex Syndrome Caused by Invasive Aspergillosis as an Adverse Effect of Systemic Chemotherapy for Metastatic Colorectal Cancer: a Case Report.
    Anticancer Res. 2016;36:821-3.
    PubMed     Text format     Abstract available


  172. KUCERA R, Topolcan O, Fiala O, Kinkorova J, et al
    The Role of TPS and TPA in the Diagnostics of Distant Metastases.
    Anticancer Res. 2016;36:773-7.
    PubMed     Text format     Abstract available


    January 2016
  173. YOSHIZUMI T, Harimoto N, Itoh S, Okabe H, et al
    Living Donor Liver Transplantation for Hepatocellular Carcinoma within Milan Criteria in the Present Era.
    Anticancer Res. 2016;36:439-45.
    PubMed     Text format     Abstract available


  174. UCHIYAMA H, Minagawa R, Itoh S, Kajiyama K, et al
    Favorable Outcomes of Hepatectomy for Ruptured Hepatocellular Carcinoma: Retrospective Analysis of Primary R0-Hepatectomized Patients.
    Anticancer Res. 2016;36:379-85.
    PubMed     Text format     Abstract available


  175. SHASTRI A, Msaouel P, Montagna C, White S, et al
    Primary Hepatic Small Cell Carcinoma: Two Case Reports, Molecular Characterization and Pooled Analysis of Known Clinical Data.
    Anticancer Res. 2016;36:271-7.
    PubMed     Text format     Abstract available


  176. AKINWANDE O, Philips P, Scoggins C, Martin RC, et al
    Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study.
    Anticancer Res. 2016;36:239-46.
    PubMed     Text format     Abstract available


  177. MASUDA GO, Yashiro M, Kitayama K, Miki Y, et al
    Clinicopathological Correlations of Autophagy-related Proteins LC3, Beclin 1 and p62 in Gastric Cancer.
    Anticancer Res. 2016;36:129-36.
    PubMed     Text format     Abstract available


    December 2015
  178. SHIRABE K, Sugimachi K, Harada N, Kayashima H, et al
    Favorable Prognosis in Patients with Sustained Virological Response to Antiviral Therapy, Including Interferon, for Chronic Hepatitis C Before Hepatic Resection for Hepatocellular Carcinoma.
    Anticancer Res. 2015;35:6963-9.
    PubMed     Text format     Abstract available


  179. SATO S, Tanaka K, Nojiri K, Kumamoto T, et al
    Hepatic Resection for Hepatocellular Carcinoma in the Elderly: Selecting Hepatectomy Procedures Based on Patient Age.
    Anticancer Res. 2015;35:6855-60.
    PubMed     Text format     Abstract available


  180. IWASE Y, Nakayama M, Yamato M, Okano T, et al
    A Biomimicking Tumor Tissue Model Using Hepatocellular Carcinoma Cell Sheet in a Collagen Sandwich System.
    Anticancer Res. 2015;35:6481-6.
    PubMed     Text format     Abstract available


  181. ENOMOTO H, Nakamura H, Liu W, Iwata Y, et al
    Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
    Anticancer Res. 2015;35:6475-9.
    PubMed     Text format     Abstract available


  182. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    Long-term Survivors After Liver Resection for Ovarian Cancer Liver Metastases.
    Anticancer Res. 2015;35:6919-23.
    PubMed     Text format     Abstract available


  183. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    Long-term Survivors After Liver Resection for Breast Cancer Liver Metastases.
    Anticancer Res. 2015;35:6913-7.
    PubMed     Text format     Abstract available


  184. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    The Role of Re-resection for Breast Cancer Liver Metastases-a Single Center Experience.
    Anticancer Res. 2015;35:6877-80.
    PubMed     Text format     Abstract available


    November 2015
  185. SUETSUGU A, Hiroshima Y, Matsumoto T, Hasagawa K, et al
    Recruitment of Cancer-Associated Fibroblasts and Blood Vessels by Orthotopic Liver Tumors Imaged in Red Fluorescent Protein (RFP) Transgenic Nude Mice.
    Anticancer Res. 2015;35:5821-5.
    PubMed     Text format     Abstract available


  186. ANDO K, Oki E, Saeki H, Kasagi Y, et al
    Number of Lymph Node Metastases May Indicate the Regimen for Adjuvant Chemotherapy in Patients with Stage III Colorectal Cancer.
    Anticancer Res. 2015;35:6207-11.
    PubMed     Text format     Abstract available


  187. MATSUMOTO H, Okumura H, Murakami H, Kubota H, et al
    Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer.
    Anticancer Res. 2015;35:6193-9.
    PubMed     Text format     Abstract available


  188. YAMADA M, Iihara H, Fujii H, Ishihara M, et al
    Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumab-induced Acneiform Rash in Metastatic Colorectal Cancer Patients.
    Anticancer Res. 2015;35:6175-81.
    PubMed     Text format     Abstract available


    October 2015
  189. URATANI R, Toiyama Y, Shimura T, Mori K, et al
    Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.
    Anticancer Res. 2015;35:5639-48.
    PubMed     Text format     Abstract available


  190. SASAKI Y, Osada S, Matsui S, Imai H, et al
    Preoperative Chemotherapy Can Change the Surgical Procedure for Hepatectomy in Patients with Liver Metastasis of Colorectal Cancer.
    Anticancer Res. 2015;35:5485-9.
    PubMed     Text format     Abstract available


  191. GIUSCA SE, Caruntu ID, Cimpean AM, Avadanei RE, et al
    Tryptase-positive and CD117 Positive Mast Cells Correlate with Survival in Patients with Liver Metastasis.
    Anticancer Res. 2015;35:5325-31.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: